Involvement of miR-30c in resistance to doxorubicin by regulating YWHAZ in breast cancer cells
AUTOR(ES)
Fang, Y., Shen, H., Cao, Y., Li, H., Qin, R., Chen, Q., Long, L., Zhu, X.L., Xie, C.J., Xu, W.L.
FONTE
Braz J Med Biol Res
DATA DE PUBLICAÇÃO
10/01/2014
RESUMO
MicroRNAs (miRNAs) are small RNA molecules that modulate gene expression implicated in cancer, which play crucial roles in diverse biological processes, such as development, differentiation, apoptosis, and proliferation. The aim of this study was to investigate whether miR-30c mediated the resistance of breast cancer cells to the chemotherapeutic agent doxorubicin (ADR) by targeting tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta (YWHAZ). miR-30c was downregulated in the doxorubicin-resistant human breast cancer cell lines MCF-7/ADR and MDA-MB-231/ADR compared with their parental MCF-7 and MDA-MB-231 cell lines, respectively. Furthermore, we observed that transfection of an miR-30c mimic significantly suppressed the ability of MCF-7/ADR to resist doxorubicin. Moreover, the anti-apoptotic gene YWHAZ was confirmed as a target of miR-30c by luciferase reporter assay, and further studies indicated that the mechanism for miR-30c on the sensitivity of breast cancer cells involved YWHAZ and its downstream p38 mitogen-activated protein kinase (p38MAPK) pathway. Together, our findings provided evidence that miR-30c was one of the important miRNAs in doxorubicin resistance by regulating YWHAZ in the breast cancer cell line MCF-7/ADR.
Documentos Relacionados
- Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells
- Clinical significance of miR-140-5p and miR-193b expression in patients with breast cancer and relationship to IGFBP5
- Emodin protects H9c2 cells from hypoxia-induced injury by up-regulating miR-138 expression
- Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal
- Overexpression of miR-484 and miR-744 in Vero cells alters Dengue virus replication